Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Walgreens Terminates Partnership With Blood Test Company, Theranos

XTALKS VITALS NEWS

Blood Test

The tests – which require just a single drop of blood – have already stopped being sold in California.

Share this!

June 14, 2016 | by Sarah Massey, M.Sc.

Tweet: Walgreens ends partnership with #Theranos. http://ctt.ec/C4nBX+

Walgreens has officially ended its partnership with medical laboratories services company, Theranos. The US pharmacy giant is set to close all 40 of the Theranos blood testing centers in its Arizona drugstores.

These locations were the last ones still operating after questions were raised regarding the accuracy of Theranos’ blood test results. The tests – which require just a single drop of blood – have already stopped being sold in California.

Loss of the Walgreens partnership is just the most recent blow to the California-based blood test company. While Theranos does operate its own retail testing centers, the Walgreens locations in Arizona were believed to bring in the majority of its customers.

The Centers for Medicare and Medicaid Services (CMS) are considering banning Theranos founder Elizabeth Holmes from operating a blood testing facility for two years, after federal regulators identified a number of issues at its lab in Newark, California. Theranos is also facing an ongoing Securities and Exchange Commission (SEC) investigation.



“In light of the voiding of a number of test results, and as the Centers for Medicare and Medicaid Services has rejected Theranos’s plan of correction and considers sanctions, we have carefully considered our relationship with Theranos and believe it is in our customers’ best interests to terminate our partnership,” said senior vice president of Walgreens, Brad Fluegel.

Formerly hailed as a Silicon Valley darling, Theranos offered fingerprick blood tests which the company claimed would be more accurate and less expensive than traditional tests. Despite voiding the results of tens of thousands of blood tests, the company has so far only corrected less than one percent of the affected results.

“We are disappointed that Walgreens has chosen to terminate our relationship and remain fully committed to our mission to provide patients access to affordable health information,” said a statement released by Theranos. “Quality and safety are our top priorities and we are working closely with government officials to ensure that we not only comply with all federal regulations but exceed them.”


Keywords: Blood Test, Theranos, Pharmacy


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
New Self-Injectable Form of Lupus Drug Approved by the FDA

July 25, 2017 - Patients with systemic lupus erythematosus (SLE) will now have the option to self-inject their medication thanks to the FDA approval of GSK’s reformulated lupus drug, Benlysta (belimumab).

Featured In: Biotech News


Canadian Chicken Farmers to Further Reduce Use of Antibiotics

July 24, 2017 - The Chicken Farmers of Canada, a national group dedicated to supporting poultry farmers and helping them meet consumer demand for chicken, has announced their strategy for eliminating the use of certain antimicrobials in meat production.

Featured In: Food News


Neonatal MRI Medical Device Approved by the FDA

July 24, 2017 - Medical device maker Aspect Imaging has received US Food and Drug Administration (FDA) approval for its Embrace Neonatal MRI System.

Featured In: Medical Device News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Manufacturing Control Strategies: What Pharmaceutical and Biotech Companies Need to Know

REGISTER FOR THESE WEBINARS

Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned


EDC and eSource: Combined for Better Data and Faster Insights


Using Model Reduction to Bridge the Quality Systems Pharmacology-Pharmacometrics Divide


How to Maximize Your Non-GLP Toxicology Studies: A Guide for Optimal Design and Methodology


Copyright © 2016-2017 Honeycomb Worldwide Inc.